Invention Grant
- Patent Title: N4 chelator conjugates
- Patent Title (中): N4螯合剂共轭物
-
Application No.: US11572161Application Date: 2005-07-19
-
Publication No.: US07767796B2Publication Date: 2010-08-03
- Inventor: Anthony Eamonn Storey , Harry John Wadsworth , Nigel Anthony Powell , Philip Duncanson
- Applicant: Anthony Eamonn Storey , Harry John Wadsworth , Nigel Anthony Powell , Philip Duncanson
- Applicant Address: GB Buckinghamshire
- Assignee: GE Healthcare Limited
- Current Assignee: GE Healthcare Limited
- Current Assignee Address: GB Buckinghamshire
- Agent Craig Bohlken
- Priority: GB0416062.8 20040719
- International Application: PCT/GB2005/002807 WO 20050719
- International Announcement: WO2006/008496 WO 20060126
- Main IPC: C07F13/00
- IPC: C07F13/00

Abstract:
The present invention provides tetra-amine chelator conjugates with biological targeting moieties, linked via a linker group and technetium complexes thereof as radiopharmaceuticals. The linker group is such that the chelator is mono-functionalized at the bridgehead position and provides both flexibility and a lack or aryl groups, to minimize lipophilicity and steric hulk. Protected versions of the chelators are provided which permit conjugation with a wide range of targeting molecules without interfering reactions with the amine nitrogens of the tetra-amine chelator. Syntheses of the functionalised chelators are described, together with bifunctional chelate precursors. Radiopharmaceutical compositions comprising the technetium metal complexes of the invention are described, together with non-radioactive kits for the preparation of such radiopharmaceuticals.
Public/Granted literature
- US20080131368A1 N4 Chelator Conjugates Public/Granted day:2008-06-05
Information query